Search results for "Plectin"

showing 4 items of 4 documents

Plectin-related scapuloperoneal myopathy with treatment-responsive myasthenic syndrome

2020

AdultMalePathologymedicine.medical_specialtyHistologymyasthenic syndromeMuskel- und KnochenstoffwechselPathology and Forensic MedicineEpidermolysis bullosa simplexAdrenergic AgentsPhysiology (medical)medicineHumansMuscular dystrophyFrameshift MutationEphedrineMyasthenic Syndromes Congenitalbusiness.industryPlectin-relatedPlectinmedicine.diseaseScapuloperoneal myopathyMuscular Dystrophy Emery-Dreifusstreatment-responsiveNeurologyPlectinNeurology (clinical)business
researchProduct

Trans-sarcolemmal proteins situated central to the subsarcolemmal region

2002

Trans-sarcolemmal proteins located inside, within, and outside of the muscle fibre plasma membrane fall into two categories, the dystrophin-glycoprotein complex (DGC) and non-DGC-related proteins, e.g. dysferlin, caveolin, dystrobrevins and syntrophins. Mutational defects are responsible for their immunohistochemical absence or reduction giving rise to certain muscular dystrophies. In other neuromuscular disorders, i.e. inflammatory, metabolic, and neurogenic processes, transarcolemmal proteins are well preserved. Unlike desmin and plectin, which form a honeycomb-type network across the muscle fibre and a subsarcolemmal layer, trans-sarcolemmal proteins are not expressed central to the subs…

HistologySarcolemmabiologyAutophagyVacuolePlectinPathology and Forensic MedicineCell biologyDysferlinNeurologyBiochemistryCrystallinPhysiology (medical)Caveolinbiology.proteinDesminNeurology (clinical)Neuropathology and Applied Neurobiology
researchProduct

Induction of rapid and reversible cytokeratin filament network remodeling by inhibition of tyrosine phosphatases

2002

The cytokeratin filament network is intrinsically dynamic, continuously exchanging subunits over its entire surface, while conferring structural stability on epithelial cells. However, it is not known how cytokeratin filaments are remodeled in situations where the network is temporarily and spatially restricted. Using the tyrosine phosphatase inhibitor orthovanadate we observed rapid and reversible restructuring in living cells, which may provide the basis for such dynamics. By examining cells stably expressing fluorescent cytokeratin chimeras, we found that cytokeratin filaments were broken down and then formed into granular aggregates within a few minutes of orthovanadate addition. After …

Tyrosine 3-MonooxygenaseRecombinant Fusion ProteinsGreen Fluorescent ProteinsIntermediate FilamentsFluorescent Antibody Techniquemacromolecular substancesBiologyCytoplasmic GranulesProtein filamentCytokeratinIntermediate Filament ProteinsKeratinTumor Cells CulturedEnzyme InhibitorsPhosphorylationCytoskeletonIntermediate filamentActinchemistry.chemical_classificationCell BiologyPlectinCell biologyLuminescent ProteinsMicroscopy ElectronEukaryotic Cells14-3-3 ProteinschemistryCytoplasmKeratinsPlectinTyrosineProtein Tyrosine PhosphatasesVanadatesJournal of Cell Science
researchProduct

Congenital myopathy and epidermolysis bullosa due to PLEC variant

2021

Abstract We report on an adult Turkish patient with mild myopathy with a fiber-type disproportion and mitochondrial disorganization caused by genetic variants in the plectin gene (PLEC). Molecular genetic panel testing revealed two homozygous variants in PLEC (NM_000445.4): c.8306C>G (p.Pro2769Arg) and c.7506 + 5C>G (p. ?) that were classified as variants of unknown significance (class 3) following ACMG guidelines for variant classification in genetic diagnostics. A thorough reassessment of the patient revealed mild skin blistering (epidermolysis bullosa simplex, EBS). This illustrates the importance of deep phenotyping of neuromuscular patients.

medicine.medical_specialtybusiness.industryGenetic variantsmedicine.diseaseDermatologyCongenital myopathyPlectin GeneEpidermolysis bullosa simplexUnknown SignificanceNeurologySkin blisteringPediatrics Perinatology and Child HealthmedicineNeurology (clinical)Epidermolysis bullosamedicine.symptomMyopathybusinessGenetics (clinical)Neuromuscular Disorders
researchProduct